ACADEMISCH ZIEKENHUIS MAASTRICHT - PHASE 2

Projektträger – zwischengeschaltetes Finanzinstitut

ACADEMISCH ZIEKENHUIS MAASTRICHT

Ort

• Niederlande

Beschreibung

Financing of the second phase of the investment programme of the University Hospital in Maastricht to be implemented over the period 2015 to 2019

Ziele

The project will support the infrastructure and organisational development of the Academisch Ziekenhuis Maastricht (University Hospital Maastricht - azM) in Maastricht, the Netherlands.

Sektor(en)

• Gesundheit

Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

EUR 105 million

Gesamtkosten (voraussichtlicher Betrag)

EUR 315 million

Umweltaspekte

Hospitals are not specifically mentioned in the Environmental Impact Assessment (EIA) Directive 2011/92/EU, though the project is covered by Annex II of the directive in relation to urban development. The Bank's services will verify the screening decision of the competent authority during appraisal and whether an EIA is required. It is expected that the project will have positive social benefits as healthcare is an element of social cohesion.

Auftragsvergabe

The Bank will require the promoter to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directive 2004/18/EC and/or 2004/17/EC as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the EU Official Journal, as and where required.

Projektstatus

Unterzeichnet - 14/12/2016